Skip to main navigation

ABOUT
MEDICINES
- POSIMIR^® (bupivacaine solution)
PIPELINE
- OVERVIEW
- LARSUCOSTEROL (DUR-928)
CLINICAL TRIALS
- AHFIRM
TECHNOLOGIES
- LONG-ACTING INJECTABLES
  - SABER® PLATFORM
  - CLOUD™ PLATFORM
- ALZET® Osmotic Pumps
INVESTORS
Investor Relations
NEWS
- NEWS RELEASES
- MEDIA KIT

INVESTORS

Investor Relations

Overview
FACTSHEETS
Stock Information
News Releases
Collaborations
Earnings Estimate
Analyst Coverage
Corporate Presentation
SEC Filings
Event Calendar
FAQs
E-mail Alerts
Information Request

E-mail Alerts

You may automatically receive DURECT Corporation financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit.

Required fields denoted by an asterisk ().

Alert type
DURECT SEC Filing Alert
DURECT Event Alert
DURECT News Alert
DURECT Financial Report Alert
DURECT Annual Report Alert

Email

Leave this field blank

Follow Us

Twitter
LinkedIn

© 2000-2022 DURECT Corporation

BUSINESS DEVELOPMENT | CAREERS | CONTACT | LEGAL NOTICE | PRIVACY POLICY